Work

Evaluation of dexamethasone effects in COVID-19 treatment

Year: 2022

Type: article

Abstract: (COVID-19) Finding a cure for Corona virus sickness in 2019 will be a difficult task for researchers all over the globe, since it is associated with significant lung damage and the potential for multiple organ failure. To far, dexamethasone has shown substantial benefits in COVID-19, reducing mortality while improving recovery. There is a reduction in inflammation due to a reduction in inflammation-related immune responses and a decrease in cytokine production, which prevents COVID-19 from becoming more severe. Dexamethasone's significance in the treatment of COVID-19 is currently unproven. When it comes to combating this pandemic, COVID-19's pathophysiology and dexamethasone's efficacy are the deciding factors.

Source: International Journal of Health Sciences

DOI: 10.53730/ijhs.v6ns1.4799

Authors: Hamza Khalifa Ibrahim, Naeimah Ahmeed Ahseen, Tousief Irshad Ahmed, Nisreen Ahmeed Ahseen, Noor-Alhooda M Al-Awkally, Aejeeliyah Yousuf

Institutions: Bani-Waleed University, Higher Institute of Medical Sciences and Technologies, University of Tripoli, Sher-i-Kashmir Institute of Medical Sciences

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4221024086

FWCI: 0.379

Cites: 20

Cited by: 3

Related to: 10